Journal
JACC-CLINICAL ELECTROPHYSIOLOGY
Volume 7, Issue 4, Pages 502-512Publisher
ELSEVIER
DOI: 10.1016/j.jacep.2020.09.010
Keywords
elevated thresholds; leadless pacemaker; predictors; system revision
Categories
Funding
- National Heart, Lung, and Blood Institute [R01HL128595]
- Abbott
- American Heart Association
- Association for the Advancement of Medical Instrumentation
- Bayer
- Boston Scientific
- Philips
- Biotronik
- Medtronic
Ask authors/readers for more resources
This study aimed to develop a predictive model for the long-term electrical performance of Micra pacemaker. Factors such as history of diabetes, male sex, elevated pacing capture threshold, and low impedance at implantation were identified as independent predictors of elevated thresholds at 12 months in patients with Micra pacemaker.
OBJECTIVES This study sought to formulate a predictive model for describing the long-term electrical performance of Micra (Medtronic, Mounds View, Minnesota). BACKGROUND The Micra leadless pacemaker is an alternative ventricular pacing option that avoids the pitfalls of transvenous leads. However, well-defined metrics to predict the long-term electrical performance of the device are lacking. METHODS We identified all patients who underwent successful Micra implantation enrolled in the investigational device exemption study, continued access study, or post-approval registry with complete 1-year post-implantation data or system revision due to elevated thresholds (N = 1,843). The analysis endpoint was an elevated pacing capture threshold (PCT) at >= 12 months post-implantation, defined as >= 2.0 V at 0.24 ms or an increase of >= 1.5 V from implantation or need for system revision due to elevated thresholds at <= 12 months post-implantation. We evaluated for univariate and multivariate associations between patient and device characteristics at implantation and for elevated thresholds at 12 months. RESULTS Among the total cohort, 75 patients (4.1%) had elevated thresholds at 12 months; of these, 13 required system revisions. Predictors associated with elevated thresholds in univariate analysis included the total number of deployments (excluded from the multivariable model), impedance and PCT at implantation, male sex, history of diabetes, and ischemic cardiomyopathy. Multivariable regression modeling found that male sex, history of diabetes, implantation PCT of >= 2 V, and impedance of <800 U were independent predictors of elevated PCT at 12 months (all p < 0.05). CONCLUSION A history of diabetes, male sex, elevated PCT, and low impedance at implantation were independent predictors of elevated thresholds at 12 months. These metrics represent the foundation of a simple tool to aid in procedural decision making. (C) 2021 by the American College of Cardiology Foundation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available